Last updated: August 10, 2026, 1:49 pm
SAAP-04 - FIP IPS Industrial Innovation Summit (supported by US Pharmacopeia)
Tracks
Room 522-A
| Saturday, August 29, 2026 |
| 9:00 AM - 5:00 PM |
Details
Organised by the FIP Industrial Pharmacy Section
Chair:
Mr. Mustafa Abacioglu, FIP Industrial Pharmacy Section Executive Committee Associate Member, Turkiye/USA
Introduction:
The FIP IPS x US Pharmacopeia - Industrial Innovation Summit brings together global leaders across the industry to highlight the essential role of industrial pharmacy in advancing patient-centred care and global health. Under the theme “One Health, One Pharmacy, One Industry – United in Innovation,” the summit will explore how industry-driven innovation strengthens resilient health systems, enhances access to high-quality medicines, and supports the One Health agenda.
Through focused discussions on manufacturing science, digital transformation, regulatory pathways, and cross-sector collaboration, participants will examine how industrial pharmacy bridges science, practice, and education. Join us as we set the stage for a more integrated and innovative future for pharmacy at the FIP World Congress in Montreal.
Programme:
Registration Fees:
The session is accessible with pre-registration only via the regular congress registration.
FIP Members: 140 Euros
Non-Members: 190 Euros
Early Career Pharmacists (ECPG Members): 110 Euros
| 09:00 – 09:30 | Keynote address: AI in drug discovery & Development: Accelerating access to impactful medicines |
| Sini Eskola, MPharm, PhDc, Head of International Regulatory Policy and Innovation at Takeda, Switzerland | |
| 09:30 – 10:15 | Pharma 4.0™: An evolution, not a revolution, in GMP data-based decision making |
| Dennis Hall, MBA – Vice President, Advanced Manufacturing Technologies at US Pharmacopeia, USA | |
| 10:15 – 10:45 | Tea break and networking |
| 10:45 – 11:15 | The missing infrastructure: How pharmacy accreditation completes the innovation pathway |
| Christine Larivière, BPharm - Co-Owner & Pharmacist, Lariviere et Massicotte, Pharmaciennes, Inc., Canada & Michael Reff, RPh, MBA – Founder & Executive Director at NCODA, USA | |
| 11:15 – 11:45 | Validating technologies in compounding medicine |
| Brian Serumaga, BPharm, MPH, PhD – Director, Personalized Medicines, US Pharmacopeia, USA | |
| 11:45 – 12:15 | Panel discussion with morning speakers |
| 12:15 – 13:00 | Lunch break |
| 13:00 – 13:45 | Addressing supply chain resilience and mitigating drug shortages |
| Dr. Jude Nwokike - Vice President, Supply Chain Resilience at U.S. Pharmacopeia, USA | |
| 13:45 – 14:30 | Pharma innovation beyond borders: Regulatory strategies to accelerate global access to healthcare products |
| Talita Ferreira, BPharm, MBA, PhD - CEO & Founder at Avanti Farmaceutica, Brazil | |
| 14:30 – 15:00 | Panel discussion with afternoon speakers |
| 15:00 – 15:15 | Closing by the chair |
